Milsaperidone FDA approval date

The FDA approved Milsaperidone (VHX-896) on 20 Feb 2026.

FDA approval date
20 Feb 2026

Drug identity checked against registry records

Also recorded as VHX-896

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-02-20DayMilsaperidoneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA220358", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["BYSANTI"], "active_ingredients": ["MILSAPERIDONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260220", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026